Trusted by the people who use it
What pathologists, researchers, and clinical teams say about working with MedMorphIQ.
I was able to use MedMorphIQ without needing any help. It’s full automation while allowing me to review and make changes, easy visualization of data made it a necessary solution for my everyday use.
In our evaluations, consistent HER2 quantification produced far more reproducible scoring across equivocal 2+ cases than manual reads, the kind of variability reduction that could meaningfully cut downstream workload in a validated workflow.
It fits the way we already work. No scanner, no new hardware, just faster, cleaner biomarker reads straight from the microscope.
The reproducibility is what won me over, the same slide returns the same index every time, which takes a real source of inter-observer variability off the table.
Proof in practice
International collaboration and research validation
A successful collaboration with Dr. Rushreeta Deuri and her team, whose evaluation work helped shape MedMorphIQ into a reliable, well-built research tool, bridging real-world relevance with technical design and demonstrating the software’s reproducibility across a range of cases.
Dr. Deuri featured MedMorphIQ in two LinkedIn posts.
A thoughtful exchange on digital pathology
Sincere thanks to Dr. Declan Fleming and his team for the opportunity to discuss cellular image processing and the broader role of technology in advancing digital pathology workflows, and for the guidance that’s shaping a potential future collaboration.